incb001158
Showing 1 - 5 of 5
Advanced Solid Tumors, Metastatic Solid Tumors Trial in Chuo Ku, Kashiwa (Retifanlimab, INCB001158, Retifanlimab + INCB001158)
Completed
- Advanced Solid Tumors
- Metastatic Solid Tumors
- Retifanlimab
- +2 more
-
Chuo Ku, Japan
- +1 more
Feb 24, 2022
Biliary Tract Cancer (BTC), Colorectal Cancer (CRC), Endometrial Cancer Trial in Belgium, United Kingdom, United States
Completed
- Biliary Tract Cancer (BTC)
- +5 more
- INCB001158
- +6 more
-
Birmingham, Alabama
- +9 more
Dec 22, 2022
Metastatic Cancer, Solid Tumors, Colorectal Cancer (CRC) Trial in Worldwide (INCB001158, Pembrolizumab)
Active, not recruiting
- Metastatic Cancer
- +9 more
- INCB001158
- Pembrolizumab
-
Mobile, Alabama
- +19 more
Aug 1, 2022
Relapsed or Refractory Multiple Myeloma Trial in Germany, Spain, United States (INCB001158, Daratumumab SC)
Completed
- Relapsed or Refractory Multiple Myeloma
- INCB001158
- Daratumumab SC
-
Daphne, Alabama
- +28 more
May 5, 2022